Skip to main content
. 2015 Aug 9;20:727–736. doi: 10.1007/s00784-015-1550-0

Fig. 6.

Fig. 6

Effect of anti-RANKL mAb on T-cells and serum calcium. The anti-RANKL mAb treatment resulted in a significant increase in CD3(+) T cells (a) and γδTCR(+) cells (b). No statistical differences were noted in the serum Ca level between the groups (c). n ≥ 7/ group; **p < 0.01, ***p < 0.001